Concepedia

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

Jesper Eugen‐Olsen, Ove Andersen, Allan Linneberg, Steen Ladelund, Tine W. Hansen, Anne Langkilde, Janne Petersen, Tomasz Pielak, Line Møller, Jørgen Jeppesen,

Journal of Internal Medicine · 2010 · 368 citations · 37 references

DOIFull text

Open access

Abstract

The stable plasma protein suPAR may be a promising biomarker because of its independent association with incident cancer, CVD, T2D and mortality in the general population.

References

37

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca et al. · New England Journal of Medicine · 2008 · 6.5K citations · Full text

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca et al. · Obstetrical & Gynecological Survey · 2009 · 3.7K citations

, , +17

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca et al. · The Lancet · 2009 · 1K citations

, , +7

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction

Paul M. Ridker, Nina P. Paynter, Nader Rifai et al. · Circulation · 2008 · 849 citations · Full text

suPAR: The Molecular Crystal Ball

Maria Thunø, Betina Macho, Jesper Eugen‐Olsen · Disease Markers · 2009 · 457 citations · Full text

, , +15